ShinglesReferencesCitationsWhitley RJ (2005). Varicella-zoster virus. In GL
Mandell et al., eds., Mandell, Douglas, and Bennett's
Principles and Practice of Infectious Diseases, 6th ed., vol. 2, pp.
1780–1786. Philadelphia: Elsevier/Churchill Livingstone. Suzuki K, et al. (2004). Detection of aerosolized
varicella-zoster virus DNA in patients with localized herpes zoster.
Journal of Infectious Diseases, 189(6):
1009–1012. Barnes SD, et al. (2005). Microbial keratitis. In GL
Mandell et al., eds., Mandell, Douglas, and Bennett's
Principles and Practice of Infectious Diseases, 6th ed., vol. 1, pp.
1395–1406. Philadelphia: Elsevier/Churchill Livingstone. Gnann JW, Whitley RJ (2002). Herpes zoster. New England Journal of Medicine, 347(5): 340–346. Ashkenazi A, Levin M (2004). Three common neuralgias:
How to manage trigeminal, occipital, and postherpetic pain. Postgraduate Medicine, 116(3): 16–48. Dubinsky RM, et al. (2004). Practice parameter:
Treatment of postherpetic neuralgia. An evidence-based report of the Quality
Standards Subcommittee of the American Academy of Neurology. Neurology, 63(6): 959–965. Jung BF, et al. (2004). Risk factors for postherpetic
neuralgia in patients with herpes zoster. Neurology,
62(9): 1545–1551. Gilden DH, et al. (2000). Neurologic complications of
the reactivation of varicella-zoster virus. New England Journal
of Medicine, 342(9): 635–645. Irwin MR, et al. (2007). Augmenting immune responses
to varicella zoster virus in older adults: A randomized, controlled trial of
tai chi. Journal of the American Geriatrics Society,
55(4): 511–517.
Other Works ConsultedGilden DH (2006). Acute viral central nervous system diseases. In DC Dale, DD Federman, eds., ACP Medicine, section 11, chap. 16. New York: WebMD. Herpes zoster vaccine (Zostavax) (2006).
Medical Letter on Drugs and Therapeutics, 48(1243):
73–74. Johnson RW, Dworkin RH (2003). Treatment of herpes
zoster and postherpetic neuralgia. BMJ, 326(7392):
748–750. Katz J, et al. (2004). Acute pain in herpes zoster and
its impact on health-related quality of life. Clinical
Infectious Diseases, 39(3): 342–348. Pregabalin (Lyrica) for neuropathic pain and epilepsy
(2005). Medical Letter on Drugs and Therapeutics,
47(1217): 75–76.
| |